High-performance liquid chromatography (HPLC) confirms safe blood levels of slow-release bupivacaine nanoparticles.
|Articles|June 30, 2004
- LCGC North America-07-01-2004
- Volume 22
- Issue 7
Supplement to GC Connections
Author(s)John V. Hinshaw
Advertisement
Articles in this issue
over 22 years ago
ChromAuctionsover 22 years ago
July TOCover 22 years ago
Molecular Movement in an HPLC Column: A Stochastic Analysisover 22 years ago
The Retention Gap Effectover 22 years ago
Peaks of Interestover 22 years ago
Divide and ConquerAdvertisement
Related to this article
Nano-liquid chromatography-high-resolution tandem mass spectrometry (nano-LC-HRMS/MS) reveals saliva protein shifts before and after multiple sclerosis therapy.
Max Besenhard explains how hybrid mechanistic and machine learning models can make HPLC method development quicker, more robust and ready for autonomous digital twins.
Ultra-high purity BIP® cylinders aim to give analytical laboratories cleaner baselines and lower detection limits
Polymer sorbent and dual microextraction boost gas chromatography with flame ionization detection (GC-FID) pesticide analysis.
Untargeted liquid chromatography–mass spectrometry (LC–MS) ties job stress in workers to plasma lipid changes.
Ultrahigh-pressure liquid chromatography–quadrupole time-of-flight mass spectrometry (UHPLC–QTOF MS) shows diet shapes honeybee metabolic responses to heat.
Advertisement
Advertisement
Trending on LCGC International
1
Industry Roundup: Air Products Advances Gas Chromatography Performance
2
Fast Low-Pressure Chiral GC for Pesticides in Wine
3
AI/ML Now: Hybrid Machine Learning for Experiment-Efficient HPLC
4
Nano-LC-MS/MS Tracks Saliva in Multiple Sclerosis
5